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Nasal cavitya b s t r a c t
The mucosal malignant melanoma arises from the melanocytes present in the mucosal membrane. It car-
ries a poor prognosis due to local recurrence, neck node involvement and distant metastasis, making it
difficult to identify the possible treatment. The key and critical issue for the management of the malig-
nant melanoma of the nasal cavity is early diagnosis in order to start primary modality of treatment like
surgical excision and radiotherapy with adequate follow up. We report a case of malignant melanoma of
the nasal cavity in a 65 years old male with presentation of recurrent epistaxis and nasal obstruction.
Rarity of this isolated lesion confined to nasal cavity with a giant size warrants its attention for reporting
this case.
 2016 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Isolated malignant melanoma of the nasal cavity is an extre-
mely rare tumour encountered by Otolaryngologists and has poor
prognosis.1 This tumour usually arises from the melanocytes which
are neuroectodermally derived cells found in the basal layer of the
skin, skin derived adnexa and some mucosal membranes. Common
locations of this lesion are head, neck and lower extremities
because they are frequently exposed to sunlight, which is a major
predisposing factor. Less frequent sites of involvement are oral cav-
ity, genitalia, conjunctiva, nail beds, orbit, esophagus, nasal cavity,
nasopharynx and leptomeninges. The peak age form mucosal mel-
anoma is between 6th to 7th decades with slight male preponder-
ance. The incidence of malignant melanoma is more among whites
than the blacks. The age and sex are not related to the prognosis of
the disease. Despite the aggressive treatment with all options
including surgery, radiotherapy and adjuvant therapy, five year
survival rate is 20–46%.2 We report a case of gaint size mucosal
malignant melanoma in the nasal cavity in a 65 years old male
without distant metastasis and locoregonal spread.2. Case report
A 65 year old male attended the out patient department of
Otorhinolaryngology with complaints of nasal obstruction and
intermittent nasal bleeding since 6 months. On examination, there
was a mass of 2  2.5 cm irregular, blackish grey in colour and fri-
able mass coming from the left nasal cavity (Fig. 1). The ears, throat
and larynx were normal on examination. He had no significant
occupational history or environmental exposure to any irritant
substance and neither had any past history of major illness. Biopsy
confirmed the diagnosis of malignant melanoma. Contrast
enhanced computed tomography (CECT) of the nose and sinuses
revealed soft tissue mass inside the nasal cavity without any exten-
sion into any paranasal sinuses, orbit and cranium (Fig. 2). There
was no neck node enlargement or any distant metastasis. The chest
X-ray showed no abnormality in the mediastinum and without any
evidence of pulmonary metastasis. The patient was underwent
complete excision of the mass by endoscopic approach. The mass
was attached to the nasal septum anteriorly. Histopathological
examination of the excised mass again confirmed the same diagno-
sis of malignant melanoma of mucosal type where pleomorphic
tumour cells revealed melanin pigments (Fig. 3). Immunohisto-
chemical analysis showed positive for S-100, HMB 45 and melan
A. Patient was given radiotherapy after surgery. He is now under
regular follow up since one year without any evidence of recur-
rence and distant metastasis.pt J Ear
Fig. 1. Patient showing a large blackish grey mass coming from the left nasal cavity.
Fig. 2. CT scan of the nose and paranasal sinuses showing a soft tissue mass inside
the left nasal cavity without any evidence of bony erosion of surrounding wall.
Fig. 3. Microphotograph showing features consistent with mucosal malignant
melanoma (Haematoxylin & Eosin 40).
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Malignant melanoma is an extremely rare and aggressive
tumour of the nasal cavity with high incidence of recurrence and
distant metastasis. Mucosal malignant melanoma in the head
and neck region are extremely rare accounting 0.4–1.8% of all
malignant melanoma.3 Most of the mucosal melanomas arises
from anorectal or are seen on the female genitalias. Commonest
sites of origin of head and neck region are sinonasal area and oral
cavity. Commonest sites of origin in nose are from lateral wall, par-
ticularly from middle and inferior turbinates followed by septum
of the nasal cavity. Isolated mucosal malignant melanoma of the
nasal cavity, nasopharynx, paranasal sinuses is aggressive disease
and fortunately rare in Indian subcontinents. The majority of this
lesion presents with nasal obstruction and recurrent epistaxis. InPlease cite this article in press as: Swain S.K., Sahu M.C. An unusual giant isolate
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deformity which are less common. There is ethnic difference with
8.8% afflicting black and Hispanics. The 5 year survival rate in
malignant mucosal melanoma range from 10% to 38%.4 The malig-
nant melanoma is characterized by early local recurrences, fre-
quent metastasis to lymph nodes and viscera, making it one of
the most fatal form of sinonasal tumour. The submandibular nodes
are most commonly affected. The nasal mucosal malignant mela-
noma is considered as one of the differential diagnosis of nasal
malignancies like carcinoma, lymphoma, sarcoma and olfactory
neuroblastoma. The only definitive prognostic factor in case of
malignant melanoma is the presence or absence of distant metas-
tasis at the time of diagnosis. Imaging should be done before taking
biopsy. CT scan and MRI are utilized to characterize this lesion. CT
scan delineates the surrounding bony erosions whereas MRI is
thought to gives accurate tumour margin in relation to the sur-
rounding structures. Ultimately tissue biopsy is the only confirma-
tory for diagnosis. The cytological picture shows cellular smears
with single cell population with large nuclear cytoplasmic ratios
and hyperchromatic nuclei. There is often multinucleated cells
are present. The pigment is seen within cytoplasm and also in
the background. Histologically, it is variable appearance and it
may look like anything.5 Grossly the size of this tumour varies from
the size of pea to giant one. Immunohistochemical study is not
usually necessary for diagnosis but useful for facilitating and com-
pleteness of the confirmatory diagnosis. S-100 and homatropine
methylbromide (HMB45) were positive for melanoma. S-100
shows high sensitive and low specificity whereas HMB45 reveals
highly specific and moderately sensitive in melanoma. If above
two stains give unclear results, another marker, a melanoma speci-
fic marker called as melan A is classically used which is highly
specific for differentiating melanoma from other malignant
growth.6 Historically, malignant melanoma was characterized as
radioresistant lesion, but recent observations are in favour that
radiotherapy has a major role in this lesion. The overall response
rate of 50–75%, if radiotherapy alone is used in localized form of
mucosal melanoma. These lesions are more radiosensitive than
their cutaneous counter parts. Surgery with radiotherapy should
be used for patients with large bulky primary lesions or with regio-
nal metastasis. Patients, who don’t agree for surgical excision or
unresectable local tumour, should be advised for radiotherapy
alone as a definitive treatment. Chemotherapy should be reserved
for patients with systemic involvement. There are several new
treatment modality like biologic and immunomodulatory thera-
peutic options are currently are being in the trial phase for the
patients of mucosal melanoma and the result of such treatment
are still eagerly awaited for successful outcome.OK-432, Inter-
leukin 2, lymphokine activated killer cells and BCG vaccine haved mucosal malignant melanoma of nasal cavity – A case report. Egypt J Ear
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successful outcome. New modality of radiotherapy like intensity
modulated radiotherapy (IMRT) and three dimensional conformal
radiotherapy (3-D-CRT) are in investigating phase and show some
promise for treating this lesion. Unfortunately the prognosis of
sinonasal mucosal melanoma is poor with a mean five year overall
survival rate is only15.7%.7 The poor prognosis of this lesion in
sinonasal area may be due to close proximity of vital structures
such as skull base, carotid artery, brain and orbit.8 The poor prog-
nostic factors associated with tumours are tumour size (>3 cm),
obstructive symptoms, advanced age, location at sinuses and
nasopharynx, vascular invasion into the skeletal muscles, high
mitotic count, cellular pleomorphism and distant metastasis.9
Other factors leading to poor prognosis are late detection and
incorrect histopathological diagnosis because of its rarity and low
index of suspicion.10
4. Conclusion
Primary mucosal malignant is an extremely rare and highly
aggressive disease of the sinonasal cavity. It typically presents with
recurrent epistaxis and nasal obstruction. Mucosal variety of
malignant melanoma as in nasal cavity has poorer prognosis than
dermal counterpart. Treatment is surgery and postoperative radio-
therapy. Close follow up is needed as local recurrence may happenPlease cite this article in press as: Swain S.K., Sahu M.C. An unusual giant isolate
Nose Throat Allied Sci (2016), http://dx.doi.org/10.1016/j.ejenta.2016.09.004and resection of the recurrent lesion results in longer survival of
the patient.
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